Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 470


Point-of-care (POC) diagnosis of bacterial vaginosis (BV) using VGTest™ ion mobility spectrometry (IMS) in a routine ambulatory care gynecology clinic.

Blankenstein T, Lytton SD, Leidl B, Atweh E, Friese K, Mylonas I.

Arch Gynecol Obstet. 2015 Feb 1. [Epub ahead of print]


Human placental growth hormone: a potential new biomarker in gestational trophoblastic disease.

Hübener C, Bidlingmaier M, Wu Z, Diebold J, Delius M, Friese K, Strasburger CJ, Hasbargen U.

Gynecol Oncol. 2015 Feb;136(2):264-8. doi: 10.1016/j.ygyno.2014.11.077. Epub 2014 Nov 29.


Lattice dynamics in intermetallic Mg2Ge and Mg2Si.

Bessas D, Simon RE, Friese K, Koza M, Hermann RP.

J Phys Condens Matter. 2014 Dec 3;26(48):485401. doi: 10.1088/0953-8984/26/48/485401. Epub 2014 Nov 6.


Understanding molecular formula assignment of Fourier transform ion cyclotron resonance mass spectrometry data of natural organic matter from a chemical point of view.

Herzsprung P, Hertkorn N, von Tümpling W, Harir M, Friese K, Schmitt-Kopplin P.

Anal Bioanal Chem. 2014 Dec;406(30):7977-87. doi: 10.1007/s00216-014-8249-y. Epub 2014 Oct 31.


Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies.

Salmen J, Neugebauer J, Fasching PA, Haeberle L, Huober J, Wöckel A, Rauh C, Schuetz F, Weissenbacher T, Kost B, Stickeler E, Klar M, Orlowska-Volk M, Windfuhr-Blum M, Heil J, Rom J, Sohn C, Fehm T, Mohrmann S, Loehberg CR, Hein A, Schulz-Wendtland R, Hartkopf AD, Brucker SY, Wallwiener D, Friese K, Hartmann A, Beckmann MW, Janni W, Rack B.

Breast Cancer Res Treat. 2014 Nov;148(1):143-51. doi: 10.1007/s10549-014-3130-4. Epub 2014 Sep 25.


Cervical conisation and the risk of preterm delivery: a retrospective matched pair analysis of a German cohort.

Kirn V, Geiger P, Riedel C, Bergauer F, Friese K, Kainer F, Knabl J.

Arch Gynecol Obstet. 2015 Mar;291(3):599-603. doi: 10.1007/s00404-014-3463-6. Epub 2014 Sep 19.


The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.

Heublein S, Mayr D, Friese K, Jarrin-Franco MC, Lenhard M, Mayerhofer A, Jeschke U.

Int J Mol Sci. 2014 Aug 27;15(9):15161-72. doi: 10.3390/ijms150915161.


Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.

Kirn V, Shi R, Heublein S, Knabl J, Guenthner-Biller M, Andergassen U, Fridrich C, Malter W, Harder J, Friese K, Mayr D, Jeschke U.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1681-7. doi: 10.1007/s00432-014-1729-9. Epub 2014 Jun 8.


Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.

Rack B, Schindlbeck C, Jückstock J, Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel K, Janni W; SUCCESS Study Group.

J Natl Cancer Inst. 2014 May 15;106(5). pii: dju066. doi: 10.1093/jnci/dju066. Erratum in: J Natl Cancer Inst. 2014 Sep;106(9):doi/10.1093/jnci/dju273.


Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer.

Jaeger BA, Jueckstock J, Andergassen U, Salmen J, Schochter F, Fink V, Alunni-Fabbroni M, Rezai M, Beck T, Beckmann MW, Friese K, Friedl TW, Janni W, Rack B.

Biomed Res Int. 2014;2014:491459. doi: 10.1155/2014/491459. Epub 2014 Apr 8.


Shaping the System - The DRG Evaluation Project of the German Society for Gynaecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, DGGG).

Fiori W, Renner SP, Siam K, Babapirali J, Roeder N, Dausch E, Hildebrandt T, Hillemanns P, Nehmzow M, Zygmunt M, Piroth D, Schem C, Schwenzer T, Friese K, Wallwiener D, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Aug;73(8):776-782.


Detection of circulating tumour cells on mRNA levels with established breast cancer cell lines.

Zebisch M, Kölbl AC, Andergassen U, Hutter S, Neugebauer J, Engelstädter V, Günthner-Biller M, Jeschke U, Friese K, Rack B.

Biomed Rep. 2013 Mar;1(2):231-234. Epub 2012 Dec 5.


Glycodelin A - a famous lipocalin and its role in breast cancer.

Kölbl AC, Jeschke U, Dian D, Friese K, Andergassen U.

Anticancer Res. 2014 Mar;34(3):1079-85. Review.


ESR1 promoter methylation in squamous cell cervical cancer.

Kirn V, Zaharieva I, Heublein S, Thangarajah F, Friese K, Mayr D, Jeschke U.

Anticancer Res. 2014 Feb;34(2):723-7.


Malnutrition and clinical outcome in gynecologic patients.

Hertlein L, Kirschenhofer A, Fürst S, Beer D, Göß C, Lenhard M, Friese K, Burges A, Rittler P.

Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:137-40. doi: 10.1016/j.ejogrb.2013.12.028. Epub 2014 Jan 14.


Validation of an anatomical coordinate system for clinical evaluation of the knee joint in upright and closed MRI.

Olender G, Hurschler C, Fleischer B, Friese KI, Sukau A, Gutberlet M, Becher C.

Ann Biomed Eng. 2014 May;42(5):1133-42. doi: 10.1007/s10439-014-0980-1. Epub 2014 Jan 28.


13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).

Untch M, Gerber B, Harbeck N, Jackisch C, Marschner N, Möbus V, von Minckwitz G, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Dimpfl T, Eiermann W, Fehm T, Friese K, Jänicke F, Janni W, Jonat W, Kiechle M, Köhler U, Lück HJ, Maass N, Possinger K, Rody A, Scharl A, Schneeweiss A, Thomssen C, Wallwiener D, Welt A.

Breast Care (Basel). 2013 Jun;8(3):221-9. doi: 10.1159/000351692.


Detection and characterisation of disseminated tumour cells in bone marrow of breast cancer patients by immunostaining of Her-2 and MUC-1 in combination with Thomsen-Friedenreich (CD176).

Andergassen U, Kölbl AC, Zebisch M, Heublein S, Hutter S, Ilmer M, Schindlbeck C, Friese K, Jeschke U.

Histol Histopathol. 2014 Jul;29(7):913-23. Epub 2014 Jan 8.


Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.

Perabò M, Fink V, Günthner-Biller M, von Bodungen V, Friese K, Dian D.

Arch Gynecol Obstet. 2014 Jun;289(6):1325-30. doi: 10.1007/s00404-013-3133-0. Epub 2014 Jan 4.


Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.

Lenhard M, Heublein S, Kunert-Keil C, Vrekoussis T, Lomba I, Ditsch N, Mayr D, Friese K, Jeschke U.

BMC Cancer. 2013 Dec 30;13:616. doi: 10.1186/1471-2407-13-616.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk